Barbara Earnest alleged that Sanofi failed to warn that hair loss, a common side effect of chemotherapy, could be permanent when using Taxotere. In 2019, a federal jury in Lousiana rejected her arguments that Taxotere was responsible.
Earnest, whose case was the first in federal multidistrict proceedings to be tried, was prejudiced by improper “quasi-expert” testimony that was offered as lay witness ...